High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control.

This study tested the hypothesis that there are consistent individual differences in the relationship between glycated hemoglobin (HbA1c) and mean blood glucose (MBG) levels in individuals with similar preceding blood glucose levels. Blood glucose data were collected for up to 2.3 years by 128 children and adolescents with type 1 diabetes. HbA1c values were date-matched with MBG levels calculated from an average of 85 self-monitored blood glucose measurements collected in the previous 30 days. There was significant linear correlation between MBG and HbA1c (HbA1c=0.027xMBG+5.8, n=682, r=.71, P<.0001) but also wide variability in the population HbA1c response to MBG. We calculated a hemoglobin glycation index (HGI=observed HbA1c-predicted HbA1c) to quantify the magnitude and direction of the difference between each patient's set of observed and predicted HbA1c results. Likelihood ratio tests and t statistics showed that mean HGI were significantly different among individuals, and that 29% of the patients had HbA1c levels that were statistically significantly higher or lower than predicted by the regression equation. The observed individual differences in the relationship between MBG and HbA1c were not related to erythrocyte age and there was no evidence of analytical artifact. We interpret these results as possible evidence of high and low hemoglobin glycation phenotypes within the population. We conclude that MBG and HbA1c are not necessarily interchangeable estimates of glycemic control and that hemoglobin glycation phenotype may be important for the clinical assessment of diabetic patients.

[1]  R Shapiro,et al.  Sites of nonenzymatic glycosylation of human hemoglobin A. , 1980, The Journal of biological chemistry.

[2]  Charles M Peterson,et al.  Tests of glycemia in diabetes. , 1995, Diabetes care.

[3]  M. Steffes,et al.  Glycohemoglobin: a primary predictor of the development or reversal of complications of diabetes mellitus. , 2001, Clinical chemistry.

[4]  R. Turner The U.K. Prospective Diabetes Study: A review , 1998, Diabetes Care.

[5]  M. Brownlee,et al.  Negative consequences of glycation. , 2000, Metabolism: clinical and experimental.

[6]  P. Higgins,et al.  Kinetic analysis of the nonenzymatic glycosylation of hemoglobin. , 1981, The Journal of biological chemistry.

[7]  D. Goldstein,et al.  What is hemoglobin A1c? An analysis of glycated hemoglobins by electrospray ionization mass spectrometry. , 1998, Clinical chemistry.

[8]  R. Craver,et al.  Quantification of hemoglobin variants by capillary isoelectric focusing. , 1994, Clinical chemistry.

[9]  J. Ditzel,et al.  Relationship between glycosylation of haemoglobin and the duration of diabetes: A study during the third trimester of pregnancy , 1982, Diabetologia.

[10]  R. Craver,et al.  Clinical Analysis of Structural Hemoglobin Variants and Hb A1c, by Capillary Isoelectric Focusing , 2001 .

[11]  E. Boyko,et al.  Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. , 1999, Diabetes care.

[12]  Rury Holman,et al.  The UK Prospective Diabetes study , 1998, The Lancet.

[13]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[14]  P. Hudson,et al.  Differences in Rates of Glycation (Glycation Index) May Significantly Affect Individual Hba1c Results in Type 1 Diabetes , 1999, Annals of clinical biochemistry.

[15]  J. Yudkin,et al.  Investigation of the mechanism underlying the variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. , 1997, Clinica chimica acta; international journal of clinical chemistry.

[16]  W. J. Griffiths,et al.  The Effect of Age on the Creatine in Red Cells , 1967, British journal of haematology.

[17]  S. Genuth,et al.  Diabetes Control and Complications Trial (DCCT): Results of Feasibility Study. The DCCT Research Group , 1987, Diabetes Care.

[18]  W Thormann,et al.  Clinical and forensic applications of capillary electrophoresis , 1994, Electrophoresis.

[19]  P. Gallop,et al.  Structural heterogeneity of human hemoglobin A due to nonenzymatic glycosylation. , 1979, The Journal of biological chemistry.

[20]  L. Kaplan,et al.  Methods in Clinical Chemistry , 1987 .

[21]  C. Jackson,et al.  Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia , 1990, Diabetologia.

[22]  E. Kilpatrick Problems in the assessment of glycaemic control in diabetes mellitus , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[23]  R. Rizza,et al.  Measurements of Glucose Control , 1987, Diabetes Care.

[24]  M. Brownlee,et al.  Advanced protein glycosylation in diabetes and aging. , 1995, Annual review of medicine.

[25]  B. Keevil,et al.  Biological Variation of Glycated Hemoglobin: Implications for diabetes screening and monitoring , 1998, Diabetes Care.